← Leaderboards
Glenn Y Ishioka
Idm Pharma, Inc.
$1,992,354
Attributed
$1,992,354
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,992,354 · 3
By mechanism
R21$826,449 · 1
R41$605,355 · 1
R43$560,550 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Neoplasm /Cancer Vaccine”
- Philip J Disaia · University Of California Irvine$19,978,203
- Robert C Park · American College Of Ob And Gyn$16,339,593
- Joseph B. Margolick · Johns Hopkins University$13,140,919
- Roger Detels · University Of California Los Angeles$12,321,518
- John W Mellors · University Of Pittsburgh At Pittsburgh$8,647,306
- Ellis L Reinherz · Dana-Farber Cancer Institute$8,556,615
Research focus
Neoplasm /Cancer VaccineTumor AntigensLaboratory MouseNeoplasm /Cancer ImmunotherapyEnzyme Linked Immunosorbent AssayHuman SubjectClinical ResearchVaccine DevelopmentHistocompatibility AntigensT LymphocyteVector VaccineClinical Trial Phase IAntigen PresentationHelper T LymphocyteDrug Screening /EvaluationNeoplasm /Cancer Relapse /RecurrenceOligonucleotidesGenetically Modified AnimalsPatient Oriented ResearchGenetic ManipulationCytotoxic T LymphocyteImmunomodulatorsBiotechnologyBreast Neoplasms
Grant awards (6)
A Multi-Epitope Vaccine for NSCLC and Colon Cancer$416,823
R21 · FY2005 · CA
A Cancer Vaccine for Ovarian and Breast Cancer$307,869
R41 · FY2005 · CA
A Multi-Epitope Vaccine for NSCLC and Colon Cancer$409,626
R21 · FY2004 · CA
A Cancer Vaccine for Ovarian and Breast Cancer$297,486
R41 · FY2004 · CA
A Multi-Epitope, Analog-Based Cancer Vaccine$283,856
R43 · FY2004 · CA
A Multi-Epitope, Analog-Based Cancer Vaccine$276,694
R43 · FY2003 · CA